Shirdi FDA Seizes 700 Kg Adulterated Prasad Peda, Vows Stricter Quality Control

Top Summary

• What happened: The Food and Drug Administration (FDA) conducted a major operation in Shirdi, seizing and destroying approximately 700 kg of adulterated and low-quality peda (sweet offering) from supply units and sales points near the Sai Baba temple complex.
• Why it matters: This action protects the health and faith of millions of devotees who consume Prasad daily, preventing the distribution of potentially harmful or unhygienic religious offerings.
• What changes: Devotees can expect stricter quality standards for Prasad at religious sites, with enhanced scrutiny on vendors and greater transparency in the supply chain to ensure product safety.
• Who is affected: Local Prasad vendors, suppliers, the Shirdi Sai Baba Institute administration, and devotees consuming offerings at the temple are directly impacted by these heightened quality control measures.

FDA Cracks Down on Adulterated Prasad in Shirdi

In a significant action aimed at ensuring the quality of offerings, Maharashtra's Food and Drug Administration (FDA) conducted a major operation in Shirdi, Maharashtra, in June 2026. The department seized and destroyed approximately 700 kilograms of adulterated and low-quality peda near the revered Sai Baba temple complex.

The extensive inspection campaign involved sudden checks at various Prasad selling centers and supply units within Shirdi. Initial tests on samples collected from multiple locations indicated that the peda did not meet required quality standards.

Investigations revealed instances of adulteration and poor storage conditions in several products. Following these findings, a substantial quantity of the sweet offering stock was immediately confiscated, with the decision to declare it unsuitable for consumption.

Stricter Oversight and Legal Consequences

The destruction of 700 kg of peda was undertaken to safeguard devotees from receiving any potentially harmful or unhygienic Prasad. FDA officials emphatically stated that no negligence regarding Prasad quality at religious sites would be tolerated.

During the operation, concerned shopkeepers and suppliers were questioned. Preliminary investigations uncovered lapses in hygiene standards and deficiencies in the quality of raw materials used by some units.

Authorities confirmed that further legal action will be initiated based on the comprehensive investigation report. This may include severe penalties such as license suspension and significant fines for those found non-compliant.

Temple Administration and Public Response

The Shirdi Sai Baba Institute administration has also responded to the incident. They affirmed that the faith and health of devotees are paramount, and ongoing monitoring of Prasad quality is a continuous effort.

"The institution will work closely with the FDA to implement even stricter standards going forward to prevent such situations from recurring," the administration stated.

Locally, the action has sent ripples of concern among Prasad vendors, with many beginning to re-check their existing stock. Devotees have shown a mixed reaction, with some welcoming the administrative crackdown and others calling for more transparent implementation.

Expert Recommendations and Future Monitoring

Experts underscore the crucial need for regular monitoring of Prasad quality at religious sites. Millions of devotees consume these offerings daily, making any form of adulteration a direct threat to public health.

The FDA has made it clear that its surveillance campaign over the Prasad supply system in Shirdi will continue indefinitely. All suppliers and shopkeepers have been issued strict instructions to adhere to quality standards rigorously.

This entire operation has brought the focus back to transparency and quality control within Shirdi's Prasad distribution, highlighting both significant questions and renewed strictness.

What to Watch Next

Future developments will involve the outcome of legal proceedings against non-compliant vendors and suppliers, including potential license suspensions and imposition of fines. Continued rigorous monitoring by the FDA is expected, alongside the Shirdi Sai Baba Institute's implementation of new, enhanced quality control standards for all religious offerings.